image
AXIS Capital Holdings Limited AXS
Financial Services - Insurance - Property & Casualty - NYSE - BM
Watchlist
$ 95.83
-2.8 %
$ 7.54 B
Market Cap
7.44
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AXS stock under the worst case scenario is HIDDEN Compared to the current market price of 95.8 USD, AXIS Capital Holdings Limited is HIDDEN

AXS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AXS stock under the base case scenario is HIDDEN Compared to the current market price of 95.8 USD, AXIS Capital Holdings Limited is HIDDEN

AXS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one AXS stock under the best case scenario is HIDDEN Compared to the current market price of 95.8 USD, AXIS Capital Holdings Limited is HIDDEN

AXS Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart AXS

image
1M -5%
6M 20%
1Y 50%
3Y 79%
5Y 220.0%
All
$105.0$105.0$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
5.96 B REVENUE
6.06%
Growth Rates
1Year 6.06%
3Years 3.83%
5Years 2.86%
7Years 3.84%
10Years 3.20%
5.28 B OPERATING INCOME
6.72%
Growth Rates
1Year 6.72%
3Years 100.24%
5Years 74.04%
7Years 57.23%
10Years 19.21%
1.08 B NET INCOME
187.49%
Growth Rates
1Year 187.49%
3Years 20.48%
5Years 27.31%
7Years 25.60%
10Years 3.00%
1.84 B OPERATING CASH FLOW
46.93%
Growth Rates
1Year 46.93%
3Years 18.28%
5Years 56.11%
7Years 32.36%
10Years 7.90%
280 M INVESTING CASH FLOW
132.78%
Growth Rates
1Year 132.78%
3Years 31.07%
5Years 18.76%
7Years 6.68%
10Years 14.34%
-417 M FINANCING CASH FLOW
-106.20%
Growth Rates
1Year -106.20%
3Years -30.89%
5Years -20.15%
7Years 3.76%
10Years 4.85%
1.58 B REVENUE
3.85%
Growth Rates
1Year 6.06%
3Years 3.83%
5Years 2.86%
7Years 3.84%
10Years 3.20%
267 M OPERATING INCOME
-22.43%
Growth Rates
1Year 6.72%
3Years 100.24%
5Years 74.04%
7Years 57.23%
10Years 19.21%
294 M NET INCOME
62.47%
Growth Rates
1Year 187.49%
3Years 20.48%
5Years 27.31%
7Years 25.60%
10Years 3.00%
356 M OPERATING CASH FLOW
-39.43%
Growth Rates
1Year 46.93%
3Years 18.28%
5Years 56.11%
7Years 32.36%
10Years 7.90%
1.39 B INVESTING CASH FLOW
298.62%
Growth Rates
1Year 132.78%
3Years 31.07%
5Years 18.76%
7Years 6.68%
10Years 14.34%
-115 M FINANCING CASH FLOW
-20.73%
Growth Rates
1Year -106.20%
3Years -30.89%
5Years -20.15%
7Years 3.76%
10Years 4.85%
Balance Sheet AXIS Capital Holdings Limited
image
Current Assets 6.92 B
Cash & Short-Term Investments 6.92 B
Receivables 0
Other Current Assets 0
Non-Current Assets 13.8 B
Long-Term Investments 13.6 B
PP&E 92.5 M
Other Non-Current Assets 150 M
33.32 %65.51 %Total Assets$20.8b
Current Liabilities 1.98 B
Accounts Payable 1.71 B
Short-Term Debt 0
Other Current Liabilities 270 M
Non-Current Liabilities 1.49 B
Long-Term Debt 1.49 B
Other Non-Current Liabilities 0
49.36 %7.77 %42.87 %Total Liabilities$3.5b
EFFICIENCY
Earnings Waterfall AXIS Capital Holdings Limited
image
Revenue 5.96 B
Cost Of Revenue 10.9 M
Gross Profit 5.95 B
Operating Expenses 666 M
Operating Income 5.28 B
Other Expenses 4.2 B
Net Income 1.08 B
6b6b5b5b4b4b3b3b2b2b1b1b006b(11m)6b(666m)5b(4b)1bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
99.82% GROSS MARGIN
99.82%
Averages
1Year 99.82%
3Years 99.80%
5Years 99.88%
7Years 99.92%
10Years 99.94%
88.63% OPERATING MARGIN
88.63%
Averages
1Year 88.63%
3Years 61.28%
5Years 38.73%
7Years 28.80%
10Years 22.86%
18.16% NET MARGIN
18.16%
Averages
1Year 18.16%
3Years 9.73%
5Years 7.68%
7Years 6.50%
10Years 6.69%
17.77% ROE
17.77%
Averages
1Year 17.77%
3Years 9.91%
5Years 7.79%
7Years 6.52%
10Years 5.79%
3.33% ROA
3.33%
Averages
1Year 3.33%
3Years 1.79%
5Years 1.44%
7Years 1.23%
10Years 1.28%
26.74% ROIC
26.74%
Averages
1Year 26.74%
3Years 13.47%
5Years 8.36%
7Years 6.74%
10Years 6.15%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis AXIS Capital Holdings Limited
image
2b2b2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 1.08 B
Depreciation & Amortization -38.4 M
Capital Expenditures 0
Stock-Based Compensation 42.7 M
Change in Working Capital 0
Others 1.82 B
Free Cash Flow 1.84 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets AXIS Capital Holdings Limited
image
Wall Street analysts predict an average 1-year price target for AXS of $85.8 , with forecasts ranging from a low of $59 to a high of $95 .
AXS Lowest Price Target Wall Street Target
59 USD -38.43%
AXS Average Price Target Wall Street Target
85.8 USD -10.47%
AXS Highest Price Target Wall Street Target
95 USD -0.87%
Price
Max Price Target
Min Price Target
Average Price Target
105105100100959590908585808075757070656560605555Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.60% DIVIDEND YIELD
0.44 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.801.801.601.601.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.290.350.380.390.410.420.430.440.440.440.290.350.380.390.410.420.430.440.440.290.350.430.440.440.351.220.381.430.381.570.391.610.391.650.41.240.41.260.411.290.411.290.420.860.420.420.430.430.440.440.440.440.440.442015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership AXIS Capital Holdings Limited
image
Sold
0-3 MONTHS
400 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
526 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
444 K USD 3
9-12 MONTHS
7. News
AXS vs. CB: Which Stock Is the Better Value Option? Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Axis Capital (AXS) and Chubb (CB). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 2 weeks ago
Are Investors Undervaluing Axis Capital Holdings (AXS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 weeks ago
Kuehn Law Encourages Investors of Axsome Therapeutics, Inc. to Contact Law Firm NEW YORK , April 8, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Axsome Therapeutics, Inc. (NASDAQ: AXSM)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Axsome caused the company to misrepresent or fail to disclose (i) Axsome's chemistry, manufacturing, and control ("CMC") practices were deficient with respect to AXS-07 and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 NDA on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the FDA reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times. prnewswire.com - 3 weeks ago
AXIS Capital to Release First Quarter Financial Results on April 30, 2025 PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the first quarter ended March 31, 2025 on Wednesday, April 30, 2025 after the close of the financial markets. Vince Tizzio, President and Chief Executive Officer, and Peter Vogt, Chief Financial Officer, will host an investor teleconference, including a question and answer period, on Thursday, May 1, 2025 at 8:30 a.m. ET. businesswire.com - 4 weeks ago
Axsome: The Alzheimer's Agitation Program For AXS-05 Axsome's AXS-05 shows strong efficacy in treating Alzheimer's Disease Agitation, with significant CMAI score reductions in multiple Phase 3 trials. The FDA has greenlit Axsome to submit an sNDA for AXS-05 without requiring new trials, based on robust existing data. AXS-05 demonstrates a favorable safety profile with low discontinuation rates due to adverse events, unlike competitors such as AVP-786 and brexpiprazole. seekingalpha.com - 1 month ago
AXS Stock Near 52-Week High: A Signal for Investors to Hold Tight? AXIS Capital gains from a well-performing specialty insurance, reinsurance as well as the accident and health portfolio. zacks.com - 1 month ago
Axis Capital (AXS) Up 3.8% Since Last Earnings Report: Can It Continue? Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock? zacks.com - 2 months ago
Edison Issues Report on Accsys Technologies (AXS) London, United Kingdom--(Newsfile Corp. - February 25, 2025) - Edison issues report on Accsys Technologies (AIM: AXS). At its investor strategy day, Accsys set financial targets for the coming years, with a combined volume and revenue CAGR of 14% for FY25-30e for the plant in the Netherlands and the Accoya USA plant (60%/40% joint venture (JV)). newsfilecorp.com - 2 months ago
AXS Stock Trading at Discount to Industry at 1.38X: Time to Hold? AXIS Capital stock is poised to gain from a well-performing specialty insurance, reinsurance as well as the accident and health portfolio. zacks.com - 2 months ago
Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade Axsome Therapeutics, Inc.'s stock has surged over 30% since my last “Hold” rating, driven by key catalysts like the litigation settlement with Teva Pharmaceuticals, announced today. Axsome's Auvelity and Sunosi are crucial, with Auvelity expected to generate over 75% of 2025 revenues; as such, today's news is a significant win. Despite high competition in MDD and other markets, Axsome's pipeline, including AXS-07 and AXS-12, shows potential for substantial revenue growth. seekingalpha.com - 2 months ago
AXIS Capital Holdings Limited (AXS) Q4 2024 Earnings Call Transcript AXIS Capital Holdings Limited (NYSE:AXS ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Cliff Gallant - Head, Investor Relations Vince Tizzio - President and Chief Executive Officer Pete Vogt - Chief Financial Officer Conference Call Participants Andrew Kligerman - TD Securities Yaron Kinar - Jefferies Brian Meredith - UBS Josh Shanker - Bank of America Charlie Lederer - BMO Operator Good morning, and welcome to the AXIS Capital Fourth Quarter 2024 Conference Call. All participants will be in a listen-only mode. seekingalpha.com - 3 months ago
AXIS Capital Q4 Earnings Top Estimates on Solid Underwriting AXS' fourth-quarter results reflect improved net investment income and higher premiums, offset by higher expenses. zacks.com - 3 months ago
8. Profile Summary

AXIS Capital Holdings Limited AXS

image
COUNTRY BM
INDUSTRY Insurance - Property & Casualty
MARKET CAP $ 7.54 B
Dividend Yield 0.60%
Description AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products worldwide. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers property insurance products for commercial buildings, residential premises, construction projects, and onshore energy installations; marine insurance products covering offshore energy, cargo, liability, recreational marine, fine art, specie, and hull war; and terrorism, aviation, credit and political risk, and liability insurance products. It also provides professional insurance products that cover directors' and officers' liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, cyber and privacy, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers. In addition, this segment offers accidental death, travel, and specialty health products for employer and affinity groups. The Reinsurance segment offers reinsurance products to insurance companies, including catastrophe reinsurance products; property reinsurance products covering property damage and related losses resulting from natural and man-made perils; professional lines; credit and surety; and motor liability products. This segment also provides agriculture reinsurance products; coverages for various types of construction risks and risks related to erection, testing, and commissioning of machinery and plants during the construction stage; marine and aviation reinsurance products; and personal accident, specialty health, accidental death, travel, life and disability reinsurance products. The company was founded in 2001 and is headquartered in Pembroke, Bermuda.
Contact AXIS House, Pembroke, HM 08 https://www.axiscapital.com
IPO Date July 1, 2003
Employees 1876
Officers Mr. David Samuel Phillips CFA Chief Investment Officer Mr. Kent W. Ziegler Global Corporate Controller & Principal Accounting Officer Mr. Clifford Henry Gallant III Head of Investor Relations & Corporate Development Mr. Peter John Vogt FSA MAAA Chief Financial Officer & Executive Vice President Mr. Conrad D. Brooks J.D. Chief Administrative & Legal Officer Mr. Daniel John Draper Group Chief Underwriting Officer Ms. Lori Bailey Head of Cyber & Technology and Global Head of Growth Mr. Vincent Christopher Tizzio President, Chief Executive Officer & Director Mr. Joseph E. Cohen APR Chief Communications Officer Stephen Lord Global Chief Information Officer